Inovio to report third quarter 2026 financial results on November 10
Biotechnology firm Inovio has scheduled its third-quarter 2026 financial results release for November 10, following the market close.
Inovio is set to announce its financial results for the third quarter of 2026 on November 10, after the conclusion of regular trading. The company plans to host a conference call and live webcast at 4:30 p.m. ET to review the quarterly performance and provide an update on its business operations.
The Pennsylvania-based biotech firm specializes in the development of DNA medicines, with a portfolio targeting HPV-related diseases, cancer, and various infectious diseases. The upcoming report follows recent regulatory developments for the company, as it continues to advance its clinical pipeline.
The event will be accessible to investors and the public via the company's investor relations portal. A replay of the discussion will remain available on the website for 90 days following the event.